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Abstract
Programmed cell death (PCD) is a fundamental mechanism in tissue and cell homeostasis. It was long suggested that
apoptosis regulates the cell number in diverse cell populations; however no clear mechanism was shown. Neutrophils are
the short-lived, first-line defense of innate immunity, with an estimated t=1/2 of 8 hours and a high turnover rate. Here we
first show that spontaneous neutrophil constitutive PCD is regulated by cell concentrations. Using a proteomic approach,
we identified the S100 A8/9 complex, which constitutes roughly 40% of cytosolic protein in neutrophils, as mediating this
effect. We further demonstrate that it regulates cell survival via a signaling mechanism involving MEK-ERK via TLR4 and
CD11B/CD18. This mechanism is suggested to have a fine-tuning role in regulating the neutrophil number in bone marrow,
peripheral blood, and inflammatory sites.
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Introduction
Programmed cell death (PCD) is a fundamental mechanism in
tissue and cell homeostasis, long thought to regulate cell number in
diverse populations. In developmental biology, PCD provides an
efficient mechanism for eliminating unwanted cells, as shown in
studies with the nematode Caenorhabditis elegans [1]. Of the 1090
somatic cells formed during the development of an adult
hermaphrodite, exactly 131 die, demonstrating the morphological
features of apoptosis. In the mammalian immune system, clonal
triggering results in lymphocyte proliferationfollowed by activation-
induced cell death that ensures T cells will return to their original
concentration, addingonlya negligiblenumber of memory cells [2].
Few studies in the human immune system have questioned the
mechanism of constitutive leukocyte blood concentration regula-
tion via PCD. In humans, neutrophils are the short-lived, first-line
defense of innate immunity, with estimated t=1/2 of 8 hours and
a high turnover rate [3]. These cells, which represent 50–60% of
the circulating leukocytes in normal conditions, are considered
terminally differentiated cells. They are rapidly recruited and
accumulate in the early phase of inflammation.
Under normal physiological conditions, absent triggers initiating
neutrophil exit from the blood pool into tissues, human blood
neutrophil counts are determined by the balance between neutrophil
hematopoiesis, neutrophil mobilization from the bone marrow, the
marginal pool, spontaneous constitutive PCD, and phagocytosis of
apoptotic neutrophils. Human neutrophils are generated in bone
marrow, mainly under the control of G-CSF and additional cytokines
and growth factors, including M-CSF, GM-CSF, IL-6, IL-3 (reviewed
by Metcalf [4]), and possibly IL-17 and IL-23 [5], as well as IL-22.
Martin et al., and others, suggested that neutrophils are retained in the
bone marrow through interaction of CXCL12 (stromal derived factor
1, or SDF-1) with its receptor CXCR4 [6–7]. In the blood pool,
neutrophils circulate until they are marginated or develop morpho-
logical changes due to PCD, and are cleared by Kupfer cells in the liver
[8] or by bone marrow macrophages [9].
Various cytokines regulate blood neutrophil counts. Catechol-
amines mobilize the marginal pool [10], while G-CSF, IL-17, and
IL-23 [5] may modify counts via bone marrow. Yet, the major
regulator of blood neutrophil counts and neutrophils at inflam-
matory sites is PCD, which allows only a short neutrophil life span,
modulated according to specific needs, such as inflammation.
Molecular events leading to this short neutrophil lifespan are
better understood now. An important regulator of neutrophil
apoptosis seems to be the Bcl-2 protein family, and a major event in
spontaneous neutrophil PCD appears related to loss of anti-
apoptotic proteins. Bcl-2 is lost during neutrophil differentiation,
and not expressed by peripheral blood neutrophils [11–14]. Bcl-xl is
also expressed by neutrophils, and expression decreases upon
TNFa-mediated apoptosis [14]. Mcl1 declines as neutrophils
undergo spontaneous apoptosis, and is upregulated when cells are
exposed to survival factors such as GMCSF, butyrate, ILb, and LPS
[12]. A1, expressedinneutrophilsat the mRNAlevel [13,15], is also
upregulated by survival factors GCSF and LPS [15]. Furthermore,
neutrophils do not express survivin, an inhibitor-of-apoptosis
protein (IAP), unless expression is induced by GCSF and GMCSF
or in inflammatory conditions [16]. In contrast, pro-apoptotic
proteins Bax, Bak, and Bad are constitutively expressed [13,14,17].
The extrinsic pathway may also be involved. Neutrophils
constitutively express Fas and Fas ligand, although the importance
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neutrophil lifeexpectancy can be modulated by various mediators (G-
CSF, GM-CSF, IL1b, IFN-gamma, and LPS [21–25]) or functional
events such as transmigration across the endothelium [26].
Despite our growing understanding of molecular control of
neutrophil PCD, it remains unclear how specific neutrophil blood
concentration is maintained. We hypothesized that cell concen-
tration might serve as a neutrophil count regulator via a feedback
mechanism affecting PCD. We examined the in vitro effect of cell
number on spontaneous neutrophil PCD, and demonstrated that
neutrophil PCD is strongly influenced by cell concentration. We
hypothesized that secreted molecules mediate this effect, and used
a proteomic approach, which showed that constitutive spontane-
ous neutrophil PCD is regulated by cell concentration through
molecules released during neutrophil PCD. We further show that
the S100 A8/9 complex is a primary regulatory molecule
regulating cell survival via CD11b/CD18 and TLR4, and through
a signaling mechanism involving MEK-ERK.
Materials and Methods
Materials
Cell culture medium consisted of RPMI 1640 (Invitrogen-
Gibco, NY) supplemented with 1% L-glutamine and 1%
penicillin/streptomycin (Biological Industries, Kibbutz Beit-Hae-
mek, Israel). The APOPTEST-FITC Kit containing Annexin V-
FITC was obtained from Nexins Research B.V. (Hoeven, The
Netherlands) or from MBL International (Cambridge, MA).
Propidium iodide (PI) was from Molecular Probes (Eugene, OR).
Recombinant proteins S100A8 and S100A9, and blocking
antibodies were generously supplied by Dr. Philippe A. Tessier.
(Laval University, Quebec, Canada). The pan-caspase inhibitor
zVAD-fmk was purchased from R&D systems (Minneapolis, MN).
Mouse anti-human CD36-PE, mouse anti-human CD11b-PE, and
isotype control IgG1-PE were obtained from Serotec (Oxford, UK),
and isotype control mouse IgM-PE from Dako (Glostrup, Denmark).
DiOC6(3) (3,3-dihexyloxacarbocyanine iodide) was purchased
from Sigma-Aldrich (St. Louis, MO). MEK inhibitor PD98059
was purchased from Cell Signaling (Danvers, MA).
Antibody against the complex S100A8/9 for flow cytometry
analysis was purchased from Abcam (Cambridge, MA).
For blocking assays, rabbit polyclonal anti-S100A9 and anti-S100A8
were generously supplied by Dr Philippe A. Tessier, and blocking
antibody against CD11b (BioLegend, San Diego, CA) was used at
different dilutions as indicated. Rabbit serum was obtained from
Jackson Laboratories (Jackson ImmunoResearch, West Grove, PA).
Cell isolation and culturing
Blood neutrophils were isolated from fresh buffy coats obtained
from healthy donors. RBCs were sedimented by adding 6%
hetastarch in 0.9% NaCl solution (Stem Cell Technologies,
Vancouver, Canada) and kept at 25uC for up to 45 min. The
leukocyte-rich upper layer of the suspension was then collected
and centrifuged on a density gradient with Ficoll-Paque (Amer-
sham Biosciences, Uppsala, Sweden). Residual erythrocytes were
removed by hypotonic lysis. Neutrophils were maintained in
suspension, at different concentrations as indicated, in RPMI 1640
medium, 1% L-glutamine, and 1% penicillin/streptomycin, in 24-
well plates at 37uC, in a humidified incubator containing 5% CO2.
Cells were .95% neutrophils as determined by morphological
analysis and .99% viable as determined by Trypan blue dye
exclusion
Apoptosis assessment. Apoptosis assessment was performed
as previously described [27] (For detailed method see – Methods S1).
Supernatant transfer
Neutrophils were suspended at concentrations of either
0.5610
6/ml or 16610
6/ml, for different times as indicated, at
37uC/5% CO2. After culturing, the supernatants of the high
concentration were collected and added to fresh neutrophils from
the same donor at concentration of 0.5610
6/ml and vice versa.
The neutrophils were then allowed to undergo constitutive
spontaneous PCD and apoptosis was detected as described.
Transmission electron microscopy
Cells werefixed in 2%glutaraldedyde in cacodylate buffer (0.1M,
PH 7.2–7.4) and washed three times in the same buffer. Cells were
then postfixed in1%OSO4for1 h at room temperature,washedin
cacodylate buffer, dedydrated in gradient series of ethanol (25%,
50%, 75%, 95%, 100%62), treated with propylene-oxide for
20 min (2 changes), and embedded in Araldite Resin. Thin sections
were prepared with an ultramicrotom and examined at an
accelerated voltage of 100KW by transmission electron microscope
(CM12, Philips, Eindhoeven, The Netherlands).
Proteomic (SDS-PAGE and MS) and Western
blotting. Proteomic (SDS-PAGE and MS) and Western
blotting were performed as previously described [28] (For
detailed method see – Methods S1).
Transfection
The two cell lines, Chinese hamster ovary (CHO), and CHO
stably transfected with complement receptor CR3, were kindly
provided by Drs. R.R. Ingalls and D.T. Golenbock, Boston
Medical Center, Boston, MA.
Leukocyte adhesion deficiency patients and controls
LAD patients signed an informed consent approved by the
Ethics Committee of Hadassah-Hebrew University Medical
Center. Controls consisted of age- and gender-matched healthy
donors, who signed an informed consent. Blood (10 ml) from
healthy donors and heparinized blood (10 ml) from patients was
drawn and evaluated on the same day.
Detection of intracellular phosphorylated ERK by flow
cytometry
For the assessment of phosphorylation of the ERK, freshly
isolated neutrophils were treated as indicated and prepared for
intracellular staining. Cells were washed with PBS, fixed with 2%
formaldehyde for 10 min at 37uC, and permeabilized with 90%
methanol for 30 min on ice. Cells then were rinsed and incubated
for 10 min at RT in PBS containing 0.5% BSA (for blocking), and
stained with either mouse anti-human phospho-p44/42 MAPK
alexa fluor 488 (Cell Signaling Technology) or isotype control
mouse IgG1 alexa fluor 488 (BioLegend).
Statistical analysis
The Student’s t test and one-way analysis of variance (ANOVA)
were used to compare mean data. The Kolmogorov-Smirnov test
was used to analyze flow cytometry results. Differences were
considered statistically significant for p,0.05.
Results
The effect of cell concentration on constitutive
spontaneous neutrophil PCD
We assumed constitutive spontaneous PCD requires one or
more autoregulatory negative feedback mechanisms exerted by
dying neutrophils that affect survival rates of the remaining cells
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at higher concentrations due to competition for nutrition and
other ingredients. We designed an experiment to examine the
effect of various cell concentrations in the physiological range
(peripheral blood neutrophil concentration ,226610
6/ml) on
the constitutive spontaneous PCD rate. A higher apoptotic cell
concentration had a protective anti-apoptotic effect, and the rate
of neutrophil PCD was inversely proportional to cell concentra-
tion, indicating an anti-apoptotic effect (Fig. 2A). Whereas
following 12h of spontaneous constitutive PCD only 5% of cells
were still alive at a concentration of 0.5610
6 neutrophils/ml, in
conditions of 32 fold concentration, at 16610
6 neutrophils/ml,
more than 40% of the cells were still alive, as shown by Annexin V
and PI negative staining (Fig. 2B) and verified by mitochondrial
potential loss studies (not shown), both methods of apoptosis
detection indicated early apoptosis state. This phenomenon was
further emphasized using cell count. There was loss of over 50% of
cells through constitutive spontaneous PCD at concentrations of
----0.5x10
6/ml for 12h (Fig. 2C), and this loss decreased in
proportion to increasing cell concentrations up to 16x10
6/ml. At
concentrations above 16x10
6/ml, there was a decline in cell
number and a prodeath effect, probably as a result of competition
for nutrition and other ingredients.
Thus, at physiological concentrations of neutrophils, there was
an anti-apoptotic effect at higher neutrophil concentrations. We
termed this a ‘‘community effect’’ _ neutrophils are encouraged to
live longer as their community is enlarged.
Factors mediating the community effect are present in
the supernatant
In order to determine whether the factor(s) responsible for the
community anti-apoptotic effect are found in the supernatant, we
exchanged media obtained from low- and high concentrations of
constitutive spontaneous neutrophil PCD. The supernatants from
high concentrations were collected and used as media for low-
concentration constitutive spontaneous neutrophil PCD of the
same donor, and the supernatants of low concentrations were used
as media for constitutive spontaneous neutrophil PCD at high cell
concentration. Media based on high-concentration PCD donors
(16610
6 cells/ml) rescued cells undergoing constitutive spontane-
ous neutrophil PCD at low concentration (0.5610
6 cells/ml) from
apoptosis, as compared with normal medium (Fig. 3A). High-
concentration medium increased the rate of viable cells from 9%
(upper left panel, Fig. 3B) to 31% (upper right panel, Fig. 3B). In
the opposite experiment, low-concentration media had no effect
on survival in high cell concentration samples (left and right lower
Figure 1. Constitutive spontaneous neutrophil PCD. A. Kinetics of spontaneous constitutive neutrophil PCD. Neutrophils were isolated and
allowed to undergo spontaneous constitutive PCD at a concentration of 1610
6/ml. Samples were obtained at the indicated intervals, and the
apoptosis rate was measured using Annexin V-FITC and PI staining. B. Transmission electron microscopy (TEM) of spontaneous constitutive
neutrophil PCD. Morphology of viable or early apoptotic (white arrow) and apoptotic (black arrows) neutrophils is shown. Apoptotic cells show the
typical morphology of condensed cytoplasm and chromatin. Cells were prepared for TEM as described in Materials and methods. C. Inhibition of
spontaneous constitutive neutrophil PCD by pan-caspase inhibitor zVAD-fmk. Sample dot plots of AnnexinV-PI staining of neutrophils undergoing
spontaneous constitutive PCD for 14 h at a concentration of 1610
6/ml, in the presence or absence of 20 mM Zvad-fmk. Pan-caspase inhibition
rescued cells from apoptotic death and viable cells are increased from 19 to 49% (p,0.001). Data are representative of 3 or more experiments.
doi:10.1371/journal.pone.0029333.g001
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experiments each and results with Annexin V were verified using
mitochondrial potential loss studies.
These results suggest that in the presence of high neutrophil
concentrations, anti-apoptotic factor(s) are secreted and provide a
survival signal to the viable neutrophil community.
Proteomic analysis of the supernatants and identification
of S100A8 and S100A9 as candidate molecules for
mediation of the community anti-apoptotic signal
We used a differentially displayed proteomic approach, as we
have previously described [28], to search for secreted factor(s) in
the supernatant that may be responsible for the ‘‘community
effect’’ on neutrophil survival.
The secreted proteomes of neutrophils undergoing constitutive
spontaneous neutrophil PCD at high concentrations (16610
6/ml)
and low concentrations (0.5610
6/ml) were collected and com-
pared by SDS-PAGE and Coomassie staining. Differentially
expressed proteins were further analyzed by mass spectrometry
(MS). Expression of two proteins, ,10 KD and ,14KD,
represented the primary difference between the supernatants
(Fig. 3C). Both were expressed at significantly greater levels in
supernatant of cells cultured at high neutrophil concentrations,
versus supernatant of cells cultured at low concentrations, despite
protein normalization according to cell number and equal protein
loading in the gel. Proteins were further identified by MS as
S100A8 and S100A9, as the best candidates for the community
effect (Table 1). The experimental approach was designed to use
2D gel; however, 1D gel identified with high certainty two
candidate proteins that were chosen for further functional studies.
Functional studies suggest that S100A8-9 mediates the
community effect
We sought to verify S100A8 and A9 mediation of the
community anti-apoptotic effect using recombinant human
S100A8 and A9 (kindly provided by Philippe A. Tessier, Laval
University, Quebec, Canada) added to neutrophils undergoing
spontaneous constitutive PCD. Increased S100A9 and S100A8/9
levels had a dramatic rescue effect on the number of neutrophils
undergoing spontaneous constitutive PCD at low cell concentra-
tions (* p,0.05), paralleling the rescue effect of the high cell
concentration supernatant (Fig. 4A). Survival increased by more
than 150%635% in the presence of 5 mg/ml of S100A8/9, as
measured by Annexin V and PI (** p,0.02). The survival effect of
S100A9 and the S100A8/9 complex was more prominent
compared to S100A9 alone. Only S100A9 had an effect already
at a concentration of 1 mg/ml. Nonetheless, S100A8 in higher
concentrations of 2 and 5 mg/ml also had a significant rescue effect
(Fig. 4A). To further verify the anti-apoptotic effect of S100A8/9,
we measured mitochondrial transmemebrane potential as an
additional early PCD evaluation, demonstrating a perfect
correlation to the Annexin V-PI measurements (Fig. 4B).
We sought to verify whether S100A9 and S100A8/9 effects are
blocked with specific antibodies, using rabbit polyclonal antibodies
raised against human S100A8 or S100A9. Antisera were used at a
range of dilutions between 1/10 and 1/10,000, as indicated.
Adding the antibodies reduced neutrophil survival by 30240% in
various dilutions (Fig. 4C), compared to control antibodies, and
induced accelerated PCD similar to that seen in spontaneous
constitutive PCD in low cell concentration supernatants. Mito-
chondrial transmemebrane potential as an additional early PCD
evaluation, demonstrated a perfect correlation to the Annexin V-
PI measurements. This further supports a role for S100A8/9 as
the main factor triggering the community anti-apoptotic effect.
S100A8/9 does not mediate the community effect via
McL1, A1, the bcl-2 protein family, or survivin
We examined the expression of different members of the PCD
intrinsic pathway, focusing on those known to be important in
neutrophil PCD. McL1, an anti-apoptotic member, was expressed by
freshly isolated neutrophils (see Figure S3), and expression was still
detected during spontaneous constitutive apoptosis. Adding S100A8/
9 did not change McL1 expression. A1 protein has alsobeen found to
be expressed in neutrophils [13,15]. We found that A1 was expressed
by freshly isolated neutrophils, with expression dramatically de-
creased during constitutive spontaneous PCD (see Figure S3). Adding
S100A8/9 did not prevent decreased A1 expression.
Bclxl was found to be expressed by freshly isolated neutrophils.
Expression was neither decreased by constitutive spontaneous
PCD, nor increased by adding S100A8/9. We also examined the
expression of Bcl2 and survivin proteins. These two proteins were
not expressed by freshly isolated neutrophils or during induction of
Figure 2. Spontaneous constitutive neutrophil PCD is cell
concentration-dependent. A. Neutrophils underwent spontaneous
constitutive PCD for 12 h at cell concentrations ranging from 0.5610
6/
ml up to 50610
6/ml. (The physiological blood concentration is
226610
6/ml.) Apoptosis was assessed by AnnexinV-FITC and PI
staining, as described in Materials and methods. Data represents the
mean 6 SD of 3 experiments. B. Sample dot plots of AnnexinV-PI
staining of neutrophils undergoing spontaneous constitutive PCD for
12 h in (a) 0.5610
6/ml, and (b) 16610
6/ml. The percentage of viable,
early (AnnexinV
+/PI
2) and late (AnnexinV
+/PI
+) apoptotic cells is
indicated within the respective quadrants. C. Survival of neutrophils
undergoing spontaneous constitutive PCD, based on cell counts. Data
presented is the mean 6 SD of 3 experiments.
doi:10.1371/journal.pone.0029333.g002
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tions that peripheral blood neutrophils don’t express these two
proteins [11214,16].
In conclusion, we could not identify an anti-apoptoticmechanism
in the main intrinsic pathway players of neutrophil PCD.
The survival effect of S100A8/9 involves the MEK-ERK
signaling pathway, and is partially mediated through
TLR4 and the integrin CD11b/CD18
S100A8 and A9 specific receptors have not yet been identified.
However, Vogl et al demonstrated that S100A8 specifically
interacts with the TLR4-MD2 complex [29], and Newton RA et
al suggested that a pertusis toxin-sensitive G-coupled protein
receptor could be the S100A9 receptor [30]. S100A8 and A9 have
been shown to exert their effects via CD36 and CD11b/CD18
(Mac-1) [30232].CD11b/CD18 is well expressed in freshly
isolated neutrophils, but CD36 is not (Fig. 5A, upper panel).
Furthermore, CD11b/CD18 was suggested as a pro-apoptotic
integrin [33,34].
Following spontaneous constitutive PCD, we detected a
homogeneous decrease in neutrophil expression of CD11b/
CD18. Gating apoptotic (Annexin V-positive) versus nonapoptotic
Figure 3. Identification of candidate molecules that induce the community effect. A. Supernatant of cells undergoing spontaneous
constitutive PCD at high concentrations has rescued cells undergoing spontaneous constitutive PCD from apoptosis at low concentrations, and
improved their survival (p,0.001). Data is representative of 3 experiments. B. Representative dot plot of supernatant transfer assay. Apoptosis was
assessed by AnnexinV and PI staining of neutrophils after 12 h of spontaneous constitutive PCD. The transfer assay was performed as follows:
neutrophils underwent spontaneous constitutive PCD at low (a, 0.5610
6/ml) or high (c, 16610
6/ml) concentration for 12 h. The supernatant of the
cells incubated at high concentrations was collected and used as media for neutrophils undergoing constitutive spontaneous PCD at low
concentrations (b), and the supernatant of the cells incubated at low concentrations was collected and used for neutrophils undergoing constitutive
spontaneous PCD at high concentrations (d). C. SDS-PAGE of differentially displayed proteins from high- and low-concentration spontaneous
constitutive PCD. The supernatants of cells undergoing spontaneous constitutive PCD at high- and low concentrations were collected, and the
proteins were purified as described in Materials and methods. Protein samples were electrophorized and stained with Coomassie, as shown. Two
proteins, ,14 KD and ,10 KD, were identified in the supernatant of cells undergoing spontaneous constitutive PCD at high concentrations (16610
6/
ml).
doi:10.1371/journal.pone.0029333.g003
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Peptide sequence
Protein score
(Mowse) Identified protein Remarks
MTCKMSQLER NIETIINTFH QYSVKLGHPD TLNQGEFKEL VRKDLQNFLK
KENKNEKVIE HIMEDLDTNA DKQLSFEEFI MLMARLTWAS HEKMHEGDEG
PGHHHKPGLG EGTP
330 S100A9 Reported role in
inflammation
MLTELEKALN SIIDVYHKYS LIKGNFHAVY RDDLKKLLET ECPQYIRKKG
ADVWFKELDI NTDGAVNFQE FLILVIKMAW QPTKKAMKKA TKSS
458 S100A8 Reported role in
inflammation
MVHLTPEEKS AVTALWGKVN VDEVGGEALG RLLVVYPWTQ RFFESFGDLS
TPDAVMGNPK VKAHGKKVLG AFSDGLAHLD NLKGTFATLS ELHCDKLHVD
PENFRLLGNV LVCVLAHHFG KKFTPPVQAA YQKVVAGVAN ALAHKYH
207 beta globin chain variant Beta globin chain
VLSPADKTNV KAAWGKVGAH AGEYGAEALE RMFLSFPTTK TYFPHFDLSH
GSAQVKGHGK KVADALTNAV AHVDDMPNAL SALSDLHAHK LRVDPWNFKL
LSHCLLVTLA AHLPAEFTPA VHASLDKFLA SVSTVLTSKY R
94 Chain C, T State Human
Hemoglobin [alpha V96w]
Hemoglobin chain
RRPDFCLEPP YTGPCKARII RYFYNAKAGL CQTFVYGGCR AKRNNFKSAE
DCMRTCGGA
113 Aprotinin Protease inhibitor
(synthetic)
Analysis of proteins identified by mass spectrometry. Sequences corresponding to the identified peptides are bolded. Score was based on molecular weight search
(MOWSE) peptide-mass database. The results identified S100A8 and S100A9 as candidate proteins.
doi:10.1371/journal.pone.0029333.t001
Figure 4. Effect of S100A9 and S100A8 on neutrophil apoptosis. A. S100A9 and S100A8 add-in experiments. Varying concentrations of
S100A9, S100A8, and the S100A8/9 complex were added to supernatants of neutrophils undergoing spontaneous constitutive PCD at a
concentration of 0.5610
6/ml. After 10 hours apoptosis was evaluated using Annexin V-PI and mitochondrial staining. Data is presented as mean 6 SD
of Annexin V-PI staining (* p,0.05, ** p,0.02). B. S100A9 and S100A8 add-in experiments. A representative sample of Annexin V-PI and
mitochondrial staining. Neutrophils undergoing spontaneous constitutive PCD without (a and c) or with (b and d) the addition of 2 mg/ml S100A8/9.
Cells were stained either with Annexin V-FITC (a and b) or with DiOC6 (c and d), as well as PI (a, b, c, d) and assessed by flow cytometry. Dot plots are
representative of 6 experiments. C. The effect of anti-S100A8 and A9 on add-in experiments. Neutrophils undergoing spontaneous constitutive PCD
at a concentration of 0.5610
6/ml for 12h, with rabbit polyclonal antibody dilutions of 1:100, 1:1000, and 1:10,000 against S100A9 and S100A8, were
then treated with 2 mg/ml S100A8/9 complex. Rabbit serum at the same dilutions of 1:100, 1:1000, and 1:10,000 was used as a control. Apoptosis was
assessed using Annexin V-FITC and PI staining. Percentages of viable, early-, and late apoptotic cells are indicated within the respective quadrants.
Dot plots are representative of 6 experiments.
doi:10.1371/journal.pone.0029333.g004
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CD18 expression on viable- versus apoptotic neutrophils
(Fig. 5A2B). Furthermore, adding S100A8/9 dramatically
upregulated CD11b/CD18, establishing a new subpopulation
with very high expression on viable cells (Fig. 5A2B).
We then blocked CD11b/CD18 prior to addition of S100A8/9.
CD11b inhibition during constitutive spontaneous neutrophil
PCD decreased cell survival by 20%, and in the presence of
S100A8/9, CD11b inhibition cut the survival effect of S100A8/9
by 50275% (Fig. 5C), suggesting that S100A8/9 may exert its
survival effect, at least in part, by either binding or expressing
CD11b, a known receptor involved in neutrophil apoptosis.
For further assessments, we used a CHO cell line transfected
with CD11b/CD18. Transfected CHO cells increased binding of
the S100A8/9 complex by almost twofold in comparison with
control CHO cells (Fig. 5C, upper right). However, when we
examined the effect of recombinant S100A8/9 on CD11b/CD18-
deficient neutrophils from a leukocyte adhesion deficiency (LAD)
patient, results were less clear. As expected, CD11b-deficient
neutrophils showed delayed PCD in comparison with neutrophils
from healthy donors (Fig. 5D), however the S100A8/9 complex
kept its protective anti-apoptotic effect on CD11b-deficient
neutrophils, and survival was increased by 50290%. This supports
the hypothesis that these proteins exert their survival effect only
partially by CD11b/CD18, and other receptors are involved. To
evaluate the role of one alternative candidate, we examined a G-
coupled protein receptor. Pertusis toxin, which abrogates G-
coupled protein receptor function, did not influence the survival
effect of S100A8/9 (Fig. 5E). An additional possible receptor is
Toll-like receptor 4 [29]. Inhibiting TLR4 abrogated the survival
effect of S100A8/9 by 25260% (Fig. 5F), suggesting that both
CD11b/CD18 and TLR4 may be involved in the pathway
enabling these proteins to affect neutrophil PCD.
Extracellular signal-regulated kinase (ERK), one of the mitogen-
activated protein kinases (MAPK), is involved in integrin signaling
and Toll-like receptors in general. It appears to mediate signals
promoting cell proliferation, differentiation, and survival, as
reviewed by Roux, et al [35]. We assessed the role of ERK in
the neutrophil S100A8/9 survival effect using intracellular staining
of phosphorylated ERK. Neutrophils exposed to S100A8/9 for
10 min showed more than a threefold increase in phosphorylation
of the ERK kinase (Fig. 6A). This activation continues to a lesser
extent following 30 and 60 min exposure. Furthermore, the
inhibitor PD98059 (MEK inhibitor) reduced ERK phosphoryla-
tion by more than 50% (Fig. 6B) and abolished the S100A8/9
survival effect by 502100% at various concentrations (Fig. 6C),
suggesting that the S100A8/9 complex survival effect involves the
MEK-ERK signaling pathway.
Apoptotic neutrophils are not activated neutrophils
As S100A8/9 was mainly reported thus far to be released
during inflammation (see discussion), it may be attributed to
release due to neutrophil activation. We wanted to further verify
that apoptotic neutrophils are not activated due to extraction
method or in vitro effect. Therefore we analyzed three surface
molecules that are upregulated upon neutrophil activation and
downregulated upon neutrophil PCD. In figures S1 and S2, CD16
and CD62L, both markers of neutrophil activation showed clear
down regulation in the examined neutrophils, in correlation to
apoptotic state [36]. In addition CD11b, is a third molecule, that is
upregulated upon activation was downregulated in apoptotic
neutrophils releasing S100A8 and S100A9 (see Figure 5). Taken
together, S100 A8 and S100A9 were released in the context of
apoptotic neutrophil death in non activated neutrophils.
Discussion
Neutrophils are responsible for the body’s rapid and effective
response to infection or injury [37]. Efficient function necessitates
an optimal balance between a sufficient number of blood
neutrophils, response to stimuli, and transmigration properties,
on one hand, against regulation of the termination of a neutrophil-
mediated inflammatory response on the other. Thus, control of
neutrophil turnover in the bone marrow and circulation, and at
inflammatory sites, is key to both homeostasis and inflammation.
PCD plays a critical role in neutrophil homeostasis for an
optimal functioning in the human body. Polymorphonuclears
comprise approximately 75% of all nucleated cells in the
Figure 5. The survival effect of S100A8/9 is mediated through CD11b/CD18 and TLR4. A. Expression of CD11b on neutrophils. Upper
panel. Freshly isolated neutrophils express CD11b/CD18 (isotype control is shown as filled histogram and anti- CD11b/CD18-PE in dotted line, middle)
but not CD36 (left). Following 12 h of spontaneous PCD (gray line, middle) there was a marked decrease in the expression of CD11b/CD18 in
comparison to freshly isolated neutrophils. Addition of S100A8/9 resulted in two different cell populations: high and low-CD11b/CD18 (black line,
right). Lower panel. Left. Correlation between CD11b and phosphatidylserine expression demonstrates that when neutrophils become apoptotic they
downregulate CD11b expression. Right. S100A8/9 upregulates CD11b expression. B. S100A8/9 dramatically increases CD11b on viable cells. Viable
cells (R1, black line) increase CD11b expression from a mean fluorescence of 552 to 1094 (p,0.0001). Apoptotic cells (R2, gray line) still maintain some
of this effect and show a mean fluorescence of 473, compared to 362 in the absence of S100A8/9. Filled histograms represent isotype control.
Neutrophils were harvested after 12 h spontaneous constitutive PCD, with or without treatment with 2 mg/ml S100A8/9. Histograms are
representative of at least 3 different experiments. C. The survival effect of S100A8/9 in the presence of anti-CD11b/CD18. Upper panel. Right.
Neutrophils were incubated for 12 h and treated with either anti-CD11b or the isotype control IgG1 before addition of S100A8/9 complex. Integrin
inhibition reduced the effect of S100A8/9 by 402100% in comparison with the isotype control (p,0.001). The average of 6 experiments is presented.
Lower panel. A representative dot plot is shown. Upper panel. Left. S100A8/9 binds to CD11b/CD18. CHO cells transfected with CR3 (black) or vector
(gray) were evaluated for S100A8/9 binding. CR3-ransfected cells bound at rates almost twofold higher than CHO control cells (median fluorescence
13.3 vs. 6.6, p,0.001). The filled curve represents isotype control; the histogram is representative of 3 experiments. D. S100A8/9 effect on neutrophils
from a CD11b/CD18-deficient patient. Neutrophil expression of CD11b from a healthy control and a patient with leukocyte adhesion deficiency is
shown in the upper panel. Spontaneous constitutive apoptosis is shown in the lower panel, together with the S100A8/9 effect. Neutrophils were
isolated from a CD11b-deficient patient and a healthy control, as described in Materials and methods, incubated at a concentration of 1610
6/ml and
allowed to undergo spontaneous constitutive PCD for 10 h, with or without addition of S100A8/9. Apoptosis was assessed by Annexin V-PI staining.
E. The survival effect induced by the complex S100A8/9 in the presence of pertussis toxin. Bordetella pertussis toxin at 100 and 500 ng/ml were added
to neutrophils 45 min before adding S100A8/9. Neutrophils then were allowed to undergo constitutive spontaneous PCD that was assessed using
AnnexinV-FITC and PI staining after 12 h. The dot plots are representative of 3 experiments. F. The survival effect of S100A8/9 in the presence of anti-
TLR4. Neutrophils were incubated for 10 h and treated with either anti-TLR4 or the isotype control IgG2a, as described in Materials and methods.
Inhibition of TLR4 abrogated the effect of S100A8/9 by 30260% (p,0.001) in comparison with the isotype control, as seen in upper panel. The upper
panel is presented as percentage of control. The experiment is a summary of four experiments (upper panel) with representative Plots in the lower
panel.
doi:10.1371/journal.pone.0029333.g005
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majority being neutrophils. Already in the bone marrow, large-
scale neutrophil death and removal of neutrophils by phagocytes
are seen [38].Yet, the major regulator of blood neutrophil counts,
as well as neutrophil counts at inflammatory sites, is PCD, which
allows only a short life span, with modulation according to needs
such as inflammation.
Here we show that the S100 A8/9 complex regulates neutrophil
number and PCD in response to neutrophil concentration, by an
anti-apoptotic effect. S100A9 (MRP14) and S100A8 (MRP8)
constitute roughly 40% of the cytosolic protein in neutrophils;
their pure abundance implies an important role in neutrophil
functions. However, our understanding of the mechanisms
implicating both molecules in neutrophil/monocyte physiology
remains incomplete, as reviewed by Nacken, et al [39].
S100A9 and S100A8 readily form hetero- and homodimeric,
trimeric, and tetrameric complexes, but apparently also exert
specific functions as monomers. It has been suggested that S100A9
plays a prominent role in leukocyte trafficking and arachidonic
acid metabolism, and elevated S100A9 and S100A8 levels are
found in body fluids of inflamed tissues. When neutrophils
undergo PCD, they release S100A8/9, which partially protects
surrounding neutrophils from PCD, a mechanism that may be of
crucial importance in fine-tuning neutrophil concentrations in the
bone marrow and blood, and in inflammatory sites. This finding is
supported by the decrease in bone marrow neutrophils in S100A9-
deficient mice [40], and the accumulation of S100A8/9 at
inflammatory sites, where prolonged survival of neutrophils is
usually needed for chemotaxis and neutrophil adhesion [32].
As shown in figure 5A and supplemental figures 1 and 2, apoptotic
neutrophils were not activated and their S100 A8 and S100 A9
release was associated with PCD and not inflammation or activation.
S100A8 deficiency is lethal [41], thus further research to gain
understanding of the role of S100A8/9 is partially limited to animal
models. By prolonging neutrophil life, S100A8/9 accumulation
could be also a contributing mechanism to autoimmune conditions
and the development of chronic inflammation or acute sterile
danger-related inflammation. In conditions such as gout, mono-
sodium urate monohydrate crystals induce the release of S100A8/
A9 from neutrophils [42] and allow inflammatory attack by
prolonging neutrophil life. High S100A8/9 levels were found in
chronically inflamed joints of patients with rheumatoid arthritis [43].
Figure 6. Effects of the S100A8/9 complex are mediated through the MAPK-ERK pathway. A. Phosphorylation of MAPK following
exposure to S100A8/9. Freshly isolated neutrophils with or without treatment with 2 mg/ml S100A8/9 for various times as indicated, and then
prepared for intracellular staining with mouse anti-human phospho-p44/42 MAPK alexa fluor 488 (gray) or isotype control (black), as described in
Materials and methods. In the presence of S100A8/9, phosphorylation was increased by 3.22-fold after 10 min (p,0.001), 1.5-fold after 30 min
(p,0.001), and decayed at 60 min (p,0.001). Histograms are representative of 3 independent experiments. B. Reduced phosphorylation of MAPK
following exposure to S100A8/9 in the presence of PD98059, a MAPK phosphorylation inhibitor. Freshly isolated neutrophils were treated with the
inhibitor PD98059 or with DMSO as a control for 30 min, and then treated with 2 mg/ml S100A8/9. Cells were then harvested and prepared for
intracellular staining of phospho-p44/42 MAPK (gray) or isotype control (black), as described in Materials and methods. Treatment with PD98059
inhibitor reduced phosphorylation caused by the S100A8/9 complex (p,0.001). Histograms are representative of 3 experiments. C. Effect of the
S100A8/9 complex in the presence of MAPK-ERK inhibitor. The effect of S100A8/9 was assessed in the presence of PD98059. Freshly isolated
neutrophils were treated with varying combinations and concentrations of DMSO (white bars), S100A8/9 complex (gray bars), or S100A8/9 complex
with PD98059 (black bars), as indicated, for 30 min before adding S100A8/9. Neutrophils were allowed to undergo constitutive spontaneous PCD.
Results represent the percentage of viable cells according to Annexin V-FITC and PI staining. Data is representative of 3 experiments (p,0.001).
doi:10.1371/journal.pone.0029333.g006
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neutropenia following chemotherapy, suggesting that low neutro-
phil concentration may be further aggravated due to accelerated
PCD, induced at low neutrophil concentrations. This hypothesis
needs further investigation.
We were also able to gain a better understanding of the
mechanism enabling S100A8/9 function. S100A8/9 clearly
upregulates and binds to CD11b, previously shown to be a major
regulator of neutrophil PCD [44], with possible anti- or pro-
apoptotic effect. However, as shown here, this effect was retained
in CD11b-deficient neutrophils, indicating additional mechanisms
such as TLR4.
Indeed, blocking TLR4 partially abrogated the S100A8/9
survival effect, suggesting that S100A8/9 is an endogenous TLR4
ligand mediating survival. It has been shown that the TLR4
agonist LPS and others inhibit neutrophil apoptosis [12,45]. Here
we show for the first time an endogenous ligand that inhibits
neutrophil apoptosis.
Our results also show a role for the MEK/ERK pathway
following activation by S100A8/9. This pathway has been well
documented to mediate signaling of both integrins and Toll-like
receptors, supporting a role for CD11b, TLR4, and possibly
additional receptors. This mechanism has been shown in the past
to be anti-apoptotic in neutrophils via both intrinsic [46] and
extrinsic [47] PCD pathways.
The correlation between beta2-integrin and TLR4 has been
suggested. These two receptors may cooperate to produce signals
that are transmitted into the cell. Also, TLR4 has been suggested
to be an ‘‘inside-out’’ regulator of the beta2-integrins [48], and
even a direct TLR4-beta2 integrin interaction has been suggested
[49].
Other possible functional proteins that could have a ‘‘commu-
nity effect’’ may be found in the secreted proteome of apoptotic
cells. An experimental approach using 2D gel may discover
additional candidate proteins and functional studies may establish
their potential role in PCD.
In summary, the physiological role of S100A8/9, the most
abundant cytosol protein in neutrophils, was not previously
understood. We propose that at physiological protein [50] and
cell concentrations, its main function is in modulating neutrophil
PCD, and that cell concentration is regulated by an autocrine and
paracrine mechanism via S100A8/9.
Finally, a biological ‘‘proof’’ is presented here, suggesting that
nature encourages ‘‘community life’’ at the level of neutrophil
survival, which could be seen as a cellular illustration for human
life.
Supporting Information
Figure S1 Apoptotic neutrophils downregulate CD16.
The expression of CD16 (Fc gamma RIII) on neutrophils. Freshly
isolated neutrophils CD16 expession at time 0 (black line, median
fluorescence of 382) and following 12 h of spontaneous PCD (gray
line, median fluorescence of 35). Isotype control is shown as filled
histogram.
(TIF)
Figure S2 Apoptotic neutrophils downregulate CD62L.
The expression of CD62L (L-selectin) on neutrophils. Freshly
isolated neutrophils CD62L expession at time 0 (black line,
median fluorescence of 791) and following 12 h of spontaneous
PCD (gray line, median fluorescence of 27). Isotype control is
shown as filled histogram.
(TIF)
Figure S3 Apoptosis-related proteins during spontane-
ous constitutive PCD in the presence of S100A8/9. SDS-
PAGE of McL1, Bcl-xl, A1, Bcl2, and survivin in spontaneous
constitutive apoptosis, with and without addition of S100A8/9.
McL1 (39 KD) and Bcl-xl (26 KD) were detected in all conditions.
A1 (20KD) was detected from freshly isolated neutrophils but
expression was downregulated significantly by spontaneous
constitutive apoptosis. Addition of S100A8/9 did not rescue
protein expression. Bcl2 (25KD) and survivin (19KD) were not
detected under any experimental conditions. The lysates of
40610
6 neutrophils under different conditions, including freshly
isolated, after 8–10 h of spontaneous constitutive PCD, or after 8–
10 h of spontaneous constitutive PCD with addition of S100A8/9,
were loaded and separated by SDS-PAGE, as described in
Experimental Procedures. Proteins were transferred to the PVDF
membrane and exposed to the appropriate primary antibody
according to manufacturers’ instructions, and then to secondary
antibody conjugated with HRP.
(TIF)
Methods S1 Additional details of methods used in proteomics
and programmed cell death evaluation.
(DOC)
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